Read + Share
Tanaka N, Mori S, Kiyotani K, Ota Y, et al. Genomic determinants impacting the clinical outcome of mogamulizumab treatment
for adult T-cell leukemia/lymphoma. Haematologica 2022 Apr 14. doi: 10.3324/haematol.2021.280352.
PMID: 35417939
|
 |
|
Tanaka N, Mori S, Kiyotani K, Ota Y, et al. Genomic determinants impacting the clinical outcome of mogamulizumab treatment
for adult T-cell leukemia/lymphoma. Haematologica 2022 Apr 14. doi: 10.3324/haematol.2021.280352.
PMID: 35417939
|
|
|
|